中基健康(000972) - 2020 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2020 was ¥2,758,230.08, a decrease of 96.99% compared to ¥91,484,302.22 in the same period last year[8] - The net profit attributable to shareholders was -¥13,041,004.34, representing a 45.43% increase in losses compared to -¥8,966,936.17 in the previous year[8] - The basic earnings per share were -¥0.0169, a decline of 45.69% compared to -¥0.0116 in the previous year[8] - Operating revenue plummeted by 96.99% to ¥2,758,230.08 compared to ¥91,484,302.22, attributed to factory shutdowns and no product sales in the first quarter[15] - The net loss for Q1 2020 was CNY 13,053,465.20, compared to a net loss of CNY 9,035,125.01 in Q1 2019, reflecting an increase in losses of approximately 44%[36] - The total comprehensive loss for Q1 2020 was -¥13,053,465.20, compared to -¥9,035,125.01 in Q1 2019, indicating a year-over-year increase in losses of about 44.7%[37] Cash Flow - The net cash flow from operating activities was -¥4,790,684.39, which is a 63.16% improvement from -¥13,002,306.18 in the same period last year[8] - Cash received from sales dropped by 99.98% to ¥4,000.00 from ¥21,623,066.04, indicating no product sales during the quarter[15] - The cash inflow from operating activities was only ¥733,296.72 in Q1 2020, a sharp decline from ¥23,488,846.89 in Q1 2019, representing a decrease of about 96.9%[44] - The company incurred a total cash outflow of ¥48,005,077.36 from financing activities in Q1 2020, compared to ¥16,172,991.27 in Q1 2019, reflecting an increase in cash outflows of about 196.5%[45] - The total cash and cash equivalents at the end of Q1 2020 were ¥26,161,078.33, down from ¥78,956,840.08 at the beginning of the period, indicating a decrease of approximately 66.8%[45] Assets and Liabilities - Total assets at the end of the reporting period were ¥674,451,770.44, down 8.89% from ¥740,282,440.65 at the end of the previous year[8] - The total liabilities decreased from CNY 292,346,652.15 at the end of 2019 to CNY 239,569,447.14 by March 31, 2020, a reduction of about 18%[30] - The total equity attributable to shareholders decreased from CNY 441,936,607.51 at the end of 2019 to CNY 428,895,603.17 by March 31, 2020, a decline of approximately 3%[30] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 36,804[10] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., Ltd., holds 16.18% of the shares[10] Operating Costs and Expenses - Operating costs fell by 96.18% to ¥3,347,191.68 from ¥87,733,345.57, reflecting the same shutdown issues[15] - Management expenses increased by 35.12% to ¥11,382,896.18 from ¥8,424,348.49 due to costs associated with the shutdown[15] - Operating expenses increased significantly, with costs rising to ¥1,752,877.32 in Q1 2020 from ¥324,951.77 in Q1 2019, marking a year-over-year increase of approximately 440.5%[39] Other Financial Metrics - The weighted average return on net assets was -3.00%, a decrease of 0.8 percentage points compared to -2.20% in the previous year[8] - The company reported no non-recurring gains or losses during the reporting period[8] - The company received no cash from investment recoveries, a 100% decrease from ¥12,889,980.00 in the previous period[16] - The company reported a financial expense of CNY 1,072,145.61 in Q1 2020, down from CNY 3,938,508.46 in the same period last year, a decrease of approximately 73%[36] Audit and Reporting - The company did not undergo an audit for the first quarter report[49] - The company did not apply new revenue and leasing standards for the current reporting period[49]